<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Polygonumins A, a new compound isolated from 
 <italic>P</italic>. 
 <italic>minus</italic>, showed promising anticancer and HIV protease inhibition activities. This compound has been filed for a Malaysian patent (PI 2014700594). In summary, our investigation provided promising results supporting the potential use of 
 <italic>P</italic>. 
 <italic>minus</italic> in the treatment of cancers such as leukaemia and colorectal and breast cancer and as an anti-HIV agent. Hopefully, these leads can be taken up for the further development of anticancer and anti-HIV drugs.
</p>
